VALENTINA GRINCHAK: Open Payments
NPI 1699490458 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 62 payments from 35 companies in 2025. Trend: 2023 $3,547 · 2024 $736 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $206 |
| Astellas Pharma US Inc | 3 | $153 |
| PFIZER INC. | 7 | $139 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| ABBVIE INC. | 3 | $62 |
| BeOne Medicines USA, Inc. | 2 | $49 |
| SpringWorks Therapeutics, Inc. | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $45 |
| GENZYME CORPORATION | 1 | $43 |
Products named: PADCEV, ERLEADA, KEYTRUDA, LUTATHERA, RYBREVANT, BRUKINSA, SARCLISA, EMRELIS.
Industry payments across NC — which companies pay providers there.
